Share This

PR Newswire Asia's news

 |   Title only   |   Print    Next page > 
     
Introducing INFINITY 2000: The Ultimate Portable Power Station
SHENZHEN, China , May 20, 2024 /PRNewswire/ -- Growatt, a leading solar energy solution company, is thrilled to announce the launch of its latest innovation —— the INFINITY 2000, a revolutionary ...
2024-05-20T    Alternative Energies   Environmental Products & Services   Green Technology 
BLUETTI Responds to Houston Storm: Seeking Relief Collaboration and Offering Tax Exemption for Texans
LAS VEGAS , May 20, 2024 /PRNewswire/ -- A severe thunderstor m swept t hrough Texas on May 17 , leaving nearly a million Houston -area residents without power. BLUETTI , an industry leader ...
2024-05-20T    Oil/Energy 
Sanya Marks Sixth Anniversary of Establishing the Hainan FTP with Pledge to Boost Global Tourism Influence
SANYA, China , May 20, 2024 /PRNewswire/ -- As Sanya marks the sixth anniversary of the Hainan Free Trade Port (Hainan FTP), the city is reflecting on its significant growth and pledging its commitment ...
2024-05-20T    Banking/Financial Service   Entertainment   Retail 
Air Premia Launches New Service on San Francisco-Incheon Route, Operating Four Times Weekly
-  This is Air Premia's third route connecting the US mainland and Korea, following similar routes to Los Angeles and New York City ...
2024-05-20T    Airlines/Aviation   Transportation   Travel 
IntouchCX Applauded by Frost & Sullivan for Enabling Seamless, Effortless, and Memorable Customer Interactions with Its Innovation-led Solutions Suite
IntouchCX's targeted and effective innovation-led solutions suite helps clients improve productivity, customer satisfaction, loyalty, and retention. ...
2024-05-20T    Computer Software   Computer/Electronics 
Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA
First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug Administration  The BLA is supported by data from the pivotal Phase 3 ALLELE study which was investigating Tab-cel in relapsed ...
2024-05-20T    Health Care/Hospital   Medical/Pharmaceuticals 
Youlife International and Distoken Acquisition Corporation Announce Definitive Business Combination Agreement
Youlife International to Go Public in the U.S. Through such Business Combination, Opening up a New Horizon for Long-Term Development ...
2024-05-20T    Banking/Financial Service   Education   Workforce Management/Human Resources 
Axonify Unveils Unified Solution to Solve Massive Frontline Employee Engagement Challenge at ATD 2024
Singular solution addresses traditional LMS limitations and ineffective engagement technology by empowering L&D, HR and Operations teams ...
2024-05-20T    Computer/Electronics   Workforce Management/Human Resources 
Certified Netflix Onboard: JMGO Officially Unveils the N1S Series Tri-Laser Projectors with Upgraded Picture Quality and Effortless Setup
Powered by Google TV and the Proprietary MALC Tri-laser Engine, the N1S Series Offers a One-Stop Home Entertainment Solution ...
2024-05-20T    Computer/Electronics   Consumer Electronics   Entertainment 
MultiMetaVerse Signs Term Sheet to Acquire Innovative E-Commerce Service Provider Bowong AI
SHANGHAI , May 20, 2024 /PRNewswire/ -- MultiMetaVerse Holdings Limited ("MMV" or the "Company"), a leading animation and entertainment company for young consumers in China , ...
2024-05-20T    Computer/Electronics   Entertainment 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.